NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) - USD ($)				3 Months Ended	9 Months Ended		12 Months Ended
	Jan. 26, 2020	Dec. 29, 2014	Dec. 26, 2014	Jun. 30, 2014	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2020
Proceeds from issuance of common stock					$ 0	$ 0
Face amount					$ 120,000
Promissory Note [Member]
Debt instrument convertible beneficial conversion feature	$ 120,000
Stock Placement [Member]
Proceeds from issuance of common stock		$ 1,625,000
Stock Placement [Member] | Promissory Note [Member]
Face amount		$ 375,000
Purchase Agreement [Member]
Payments to acquire residential real estate							$ 4,000,000
Payments to acquire real estate							12,000,000
Payments to develop real estate assets							3,000,000
Payments to acquire and develop real estate							$ 825,000
Common Stock [Member] | Stock Placement [Member]
Sale of stock number of shares issued in transaction		2,000,000
Sale of stock consideration received on transaction		$ 2,000,000
Ms Kurland [Member]
Shares forfeited			15,000,000
Director [Member]
Stockholders equity reverse stock split			board of directors approved a 15.04 to one stock split (“Stock Split”) in the form of a stock dividend to holders of our common stock as of that date. To affect that board action, each recipient of the stock dividend would receive 14.04 additional shares of common stock
Bling Marketing Inc [Member]
Sales revenue				$ 22,025
Nu Gene Inc [Member] | Nugene Merger Agreement [Member] | Series A Preferred Stock [Member]
Stock issued during period shares new issues			1,917,720
Nu Gene Inc [Member] | Common Stock [Member] | Nugene Merger Agreement [Member]
Stock issued during period shares new issues			26,052,760
Nu Gene Inc [Member] | Ms Kurland [Member]
Payments to acquire business net of cash acquired			$ 350,000
Common stock, percentage			95.00%
Nu Gene Inc [Member] | Director [Member] | Nugene Merger Agreement [Member] | Series A Preferred Stock [Member]
Stock issued during period shares new issues			900,000